Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
The purpose of this trial is to study the clinical effects of increasing the weekly fraction
number for locally advanced head and neck cancers by a multi-institutional prospective
randomised trial. The primary endpoint is to clarify whether a six fraction per week
protocol has a greater effect on the survival, as compared to the conventional five fraction
per week protocol.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Three Years Loco-regional Control
Eduardo Rosenblatt, M.D.
International Atomic Energy Agency (IAEA)
United Nations: International Atomic Energy Agency